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http://dx.doi.org/10.1016/j.jaad.2013.12.034Fig 1. Ecthyma gangrenosum in neonatal chronic granu-
lomatous disease. Multiple deep ulcerations of the left
buttock, right perianal area, and perineum following 2
days of antibiotic therapy and wound care.
Fig 2. Ecthyma gangrenosum in neonatal chronic granu-
lomatous disease. Dramatic healing of ulcerations
following 9 days of antibiotic therapy and wound care.Chronic granulomatous disease presenting
with ecthyma gangrenosum in a neonate
To the Editor: While the primary immunodeficiency
chronic granulomatous disease (CGD) frequently
presents with cutaneous manifestations, associated
ecthyma gangrenosum (EG) has rarely been re-
ported. EG is an ulcerative infection, typically caused
by Pseudomonas aeruginosa in immunocompro-
mised patients. We report a 23-day-old male with
EG due to Klebsiella oxytoca, who was subsequently
diagnosed with CGD. This case emphasizes the
importance of initiating broad antibiotic coverage
and immunologic work-up in infants with EG.
A 23-day-old term male presented to our institu-
tion febrile with temperature up to 39.28C and a 1-
week history of erythema of the perineum that
progressed to pustules and ulcerations. Family and
social histories were noncontributory. Upon admis-
sion, vancomycin and acyclovir were initiated by the
pediatrics team.
Because the ulcerations were not improving, a
dermatology consult was initiated. Upon examina-
tion, irregularly shaped ulcerations were noted in the
perineum and buttocks (Fig 1). Given concern for
EG, ceftazidime was added. Wound care included
gentamicin ointment andwhite petrolatum.Work-up
was significant for leukocytosis and elevated band
count. Blood cultures, herpes simplex virus poly-
merase chain reaction, and lesional viral cultures
were negative. Bacterial wound cultures grew
Klebsiella oxytoca and Enterococcus faecium, con-
firming a diagnosis of EG. Klebsiella oxytoca was
thought to be the primary pathogen, but antibiotics
also covered Enterococcus faecium. The patient’s
ulcerations dramatically improved within 1 week of
antimicrobial therapy (Fig 2).
Diagnosis of EG prompted an immunologic
investigation that was remarkable for dihydrorhod-
amine 123 (DHR); flow cytometric analysis showed
no granulocyte oxidase activity. Work-up of the
patient’s mother showed oxidative abnormalities in
70% of granulocytes, confirming X-linked CGD in
our patient. After diagnosis, the patient was started
on prophylactic itraconazole, trimethoprim/sulfa-
methoxazole, and interferon-gamma.Open access under CC BY-NC-ND license.CGD is a rare primary immunodeficiency caused
by defective formation of the phagocyte respiratory
burst. It results in recurrent bacterial and fungal
infections, which can lead to granuloma forma-
tion.1-3 Cutaneous infections affect 60% to 70% of
patients with CGD.2 Inheritance of CGD is usually
X-linked, but can be autosomal recessive. DHR has
replaced nitroblue tetrazolium as the confirmatory
test given its ability to differentiate subtypes.
In our patient, EG was the presenting manifestation
of CGD. EG has been reported only once
previously with CGD; however, that pathogen
was Chromobacterium violaceum.1 EG is a rare infec-
tion, characteristically seen in immunocompromised
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typically arises from hematogenous seeding, but can
occur with direct bacterial inoculation through skin.4 It
begins as painless erythema that rapidly progresses to
bullae and pustules. Deep ulcers eventually form with
surrounding erythema.5
Pseudomonas aeruginosa classically causes EG,
but other pathogens have been reported. If EG is
suspected, bacterial cultures from cutaneous lesions
and blood cultures should be obtained. Because
significant morbidity is associated with EG, broad
spectrum antimicrobial coverage should be initiated
until a pathogen is identified.
Early diagnosis of CGD is vital to help prevent
future complications, in that antimicrobial prophy-
laxis is usually initiated to prevent recurrent in-
fections. Immunotherapy with interferon-gamma
may be beneficial in some cases, while definitive
treatment for CGD is stem cell transplantation.3 This
case underscores the need for comprehensive immu-
nologic evaluation of infants with EG.
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dermoscopically mimicking basal cell
carcinoma
To the Editor: Tubular apocrine adenoma (TAA) is a
rare benign sweat gland tumor, typically presenting
as a well-defined, red to brownish nodule on the
scalp. TAA is histologically characterized by a well-
circumscribed intradermal mass comprising tubular
structures lined with two rows of epithelial cells.1,2
The cells forming the tubular structures show
apocrine differentiation with decapitation secre-
tion.1,2 Although TAA has been histologically well
characterized, the dermoscopic features of TAA have
not been reported. Here, we present a case of TAA
with dermoscopic findings that are indistinguishable
from those of basal cell carcinoma (BCC).
A 63-year-old man presented with a 2-month
history of a small black papule progressively growing
on his face. On physical examination, a 3-mm-
diameter well-circumscribed black papule with a
pearly border was seen on his left cheek (Fig 1, A).
Dermoscopic examination revealed telangiectasias
and round or oval bluish gray areas that we consid-
ered to be short fine telangiectasias (SFTs) and large
blue-gray ovoid nests, respectively (Fig 1, B). From
the clinical and dermoscopic findings, BCC was
initially suspected. Histology showed a number of
irregularly shaped tubular structures in thedermis (Fig
2). Telangiectasias were also evident in the upper
dermis. The tubular structures contained 2 or more
layers of epithelial cells filledwith abundant redblood
cells (RBCs) and eosinophilic fluid. The luminal layer
of the tubular structures was composed of columnar
cells, and the outer layer consisted of cuboidal cells.
The luminal cells showed active decapitation secre-
tion. Immunohistochemically, positive staining for
gross cystic disease fluid protein-15 was observed in
the columnar and cuboidal cells and the luminal
fluids. The tumor cells showed no significant nuclear
atypia or mitotic figures. Neither epidermal invagina-
tion nor infiltration of plasma cells was seen. These
findings collectively supported a diagnosis of TAA.
Clinically, a black lesion with a pearly border
developed on our patient’s face and showed SFTs
and large blue-gray ovoid nests under dermoscopy.
Therefore, we initially diagnosed the lesion as BCC.
However, subsequent histologic examinations led to
a diagnosis of TAA. To our knowledge, to date, no
case of TAA showing clinical or dermoscopic resem-
blance to BCC has been reported. Notably, both SFTs
and well-established large blue-gray ovoid nests
were observed in the same lesion, although
their coexistence is rare in BCC.3 Moreover, large
blue-gray ovoid nests were arranged in a floriform
